Tumores Urológicos

Estudo de coorte | Desfechos de sobrevida associados com nefrectomia citorredutora em pacientes com carcinoma renal mestastático de células claras.

18 Mai, 2022 | 16:43h

Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma – JAMA Network Open

 

Comentário no Twitter

In this cohort study, instrumental variable analysis did not find a survival advantage associated with cytoreductive nephrectomy for patients with metastatic clear cell renal cell carcinoma. https://t.co/iljbmtZW4f

— JAMA Network Open (@JAMANetworkOpen) May 16, 2022

 

---

Estudo randomizado | Efeito da cistectomia radical assistida por robô com derivação urinária intracorpórea vs. cistectomia radical aberta sobre a morbidade e a mortalidade de 90 dias entre pacientes com câncer de bexiga.

17 Mai, 2022 | 12:11h

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial – JAMA

Editorial: Robotic Surgery for Bladder Cancer – JAMA

 

Comentário no Twitter

In this trial, robot-assisted surgery vs open surgery for radical cystectomy among patients with #bladdercancer resulted in a statistically significantly greater number of days alive and out of the hospital. https://t.co/icPLiKH0Lf

— JAMA (@JAMA_current) May 15, 2022

 

---

Diretriz AUA/ASTRO | Câncer de próstata clinicamente localizado.

16 Mai, 2022 | 16:35h

Página principal: Clinically Localized Prostate Cancer: AUA/ASTRO Guideline – American Urological Association

Part I: Introduction, Risk Assessment, Staging and Risk-Based Management

Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

Part III: Principles of Radiation and Future Directions

Conteúdos relacionados:

Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy – European Urology

Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review – The Journal of Urology

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial – The Lancet Oncology

German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy – Urologia Internationalis

Therapies for Clinically Localized Prostate Cancer – Agency for Healthcare Research and Quality

Radical prostatectomy versus deferred treatment for localised prostate cancer – Cochrane Library

---

Revisão | Avaliação e tratamento da função cognitiva de pacientes com câncer de próstata tratados com inibidores do receptor androgênico de segunda geração.

12 Mai, 2022 | 14:18h

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors – CNS Drugs

---

Opções de tratamento de resgate de primeira linha para pacientes com tumor de células germinativas cujo tratamento primário adaptado ao estágio falhou.

10 Mai, 2022 | 12:14h

First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment – World Journal of Urology

---

Revisão | Abordagem global para melhorar o cuidado no câncer peniano.

6 Mai, 2022 | 17:20h

A global approach to improving penile cancer care – Nature Reviews Urology (se o acesso a este link for pago, tente este)

---

Estudo randomizado | Melhora de sobrevida com enzalutamida em pacientes com câncer de próstata metastático sensível a hormônio.

4 Mai, 2022 | 13:39h

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer – Journal of Clinical Oncology

Estudo original: ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer – Journal of Clinical Oncology

 

Comentário no Twitter

🆕 #JCO #ClinicalTrialUpdate: ARCHES trial – 📈 Enzalutamide + ADT improved OS in men with metastatic horomone-sensitive #ProstateCancer 👉 https://t.co/FQ1lViCTZz #PCSM @AarmstrongDuke pic.twitter.com/fLs6PdFYlr

— Journal of Clinical Oncology (@JCO_ASCO) April 27, 2022

 

---

Diretriz | Tratamento de pequenas massas renais.

29 Abr, 2022 | 15:08h

Canadian Urological Association guideline: Management of small renal masses – Canadian Urological Association Journal

Ver também: Summary of Recommendations

---

Revisão | Teste germinativo e aconselhamento genético no câncer de próstata.

29 Abr, 2022 | 14:55h

Germline testing and genetic counselling in prostate cancer – Nature Reviews Urology (se o acesso a este link for pago, tente este no PMC)

---

M-A | Intensificação da terapia sistêmica em adição a tratamento local definitivo no câncer de próstata não metastático desfavorável.

27 Abr, 2022 | 16:16h

Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis – European Urology

---